Insulin, fast-acting (human)

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC A10AB01
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector INSULIN_SHORT_HUMAN

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 4727 2338 2389
Unadjusted prevalence (%) 1.82 1.59 2.11
Mean age at first event (years) 27.69 26.74 28.62

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 4.42 [3.40, 5.74] 1.1e-28 639
15 years 0.03 4.64 [3.76, 5.72] 1.2e-46 435
5 years 0.00 4.88 [3.89, 6.13] 1.6e-42 117
1 year - - - -

Correlations

Index endpoint: INSULIN_SHORT_HUMAN – Insulin, fast-acting (human)
GWS hits:

Survival analyses between endpoints

Plot

before Insulin, fast-acting (human)
after Insulin, fast-acting (human)

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Insulin, fast-acting (human)